🟢 TransMedics Group is trading 40.21% up in after-hours trading — no confirmed catalyst identified

TransMedics Group is trading 40.21% up at $123.48 in after-hours trading, with no confirmed company-specific catalyst identified.

• The company closed at $88.07 on September 22, 2026.
• On September 10, Fernando Araujo became CFO, and the company reaffirmed 2026 revenue guidance of $737 million to $757 million.
• No confirmed September 22 earnings release, FDA decision, acquisition or other major company-specific catalyst was identified; the after-hours gain remains unexplained.